Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2014-07-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Daily Eating Patterns for Total Health Study
NCT06455995
Effects of Two-weeks of Time Restricted Feeding on Basal and Postprandial Metabolism in Healthy Men
NCT03969745
Lifestyle, Eating, and Activity Patterns
NCT00944099
Does Meal Timing Affect Energy Expenditure
NCT02247076
Pilot Study of Time Restricted Feeding as a Weight Loss Intervention
NCT03571048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MORNING
Participants will be instructed to consume 50% of their energy intake in their first eating bout, 30% in their second eating bout, and 20% in their third eating bout. For example, a participant prescribed a 1200 kcal/d diet needs to consume 600 kcal in their first eating bout, 360 kcal in their second bout, and 240 kcal in their third bout. Participants will be provided with sample meal plans meeting this prescription.
Eat majority of calories in the morning
EVENING
Participants will be instructed to consume 20% of their energy intake in their first eating bout, 30% in their second eating bout, and 50% in their third eating bout. For example, a participant prescribed a 1200 kcal/d diet needs to consume 240 kcal in their first eating bout, 360 kcal in their second bout, and 600 kcal in their third bout. Participants will be provided with sample meal plans meeting this prescription.
Eat the majority of calories in the evening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eat majority of calories in the morning
Eat the majority of calories in the evening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal self-reported daily (weekday and weekend) wake-up time between 5 am and 8 am
* normal, self-reported weekend wake-up time within two hours of their normal, self-reported weekday wake-up time
* regularly (at least five nights/week) get at least six total hours of self-reported sleep
Exclusion Criteria
* report being unable to walk for 2 blocks (1/4 mile) without stopping
* are currently participating in a weight loss program and/or taking weight loss medication or lost \> 5% of body weight during the past 6 months
* are diagnosed with type 1 or 2 diabetes
* have had bariatric surgery or are planning to have bariatric surgery within the next 4 months
* intend to move outside of the metropolitan area within the time frame of the investigation
* are pregnant, lactating, \< 6 months post-partum, or plan to become pregnant during the investigation
* are taking mediation to aid in sleep
* are shift workers/alternative shift workers that work outside of 7 am and 7 pm
* have a metal allergy (which would prevent the ability of participant to wear the SenseWear® armband from BodyMedia® used in the proposed study).
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Tennessee, Knoxville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hollie Raynor
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hollie Raynor, Ph, RD
Role: PRINCIPAL_INVESTIGATOR
University of Tennessee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Tennessee--HEAL Lab
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
HEAL research information website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTK_9560 B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.